Skip to search formSkip to main contentSkip to account menu

264W 94

Known as: 264W94 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazepines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
[The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs].
Inhibition of the apical sodium-dependent bile acid transporter (ASBT, also known as IBAT - ileal bile acid transporter, SLC10A2… 
Highly Cited
2013
Highly Cited
2013
Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes.
The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract… 
Highly Cited
2012
Highly Cited
2012
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.
Bile acids are recognized as metabolic modulators. The present study was aimed at evaluating the effects of a potent Asbt… 
Highly Cited
2002
Highly Cited
2002
Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94 DOI 10.1194/jlr.M200121-JLR200
264W94 was designed to inhibit the ileal bile acid transporter (IBAT). Evaluated in vitro, 264W94 dose-dependently inhibited… 
Highly Cited
1999
Highly Cited
1999
Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.
The relationship between biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats was examined. The biliary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)